| Erika Lanet Pickens, LPN | |
|
1432 Stuckey Rd, Dubberly, LA 71024-2814 | |
| (318) 268-0629 | |
| Not Available |
| Full Name | Erika Lanet Pickens |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1432 Stuckey Rd, Dubberly, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578070405 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 230575 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erika Lanet Pickens, LPN 1432 Stuckey Rd, Dubberly, LA 71024-2814 Ph: () - | Erika Lanet Pickens, LPN 1432 Stuckey Rd, Dubberly, LA 71024-2814 Ph: (318) 268-0629 |
News Archive
The Food and Drug Administration's Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.
Bipolar disorder, commonly known as manic-depressive disorder, is highly influenced by the circadian system - the body's internal clock - and a specific kind of psychotherapy may help decrease irregularities in the circadian system that can trigger key symptoms of bipolar disorder, according to a study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.
The U.S. Food and Drug Administration has approved Alimta (pemetrexed), the first drug available for maintenance therapy of advanced or metastatic lung cancer.
By carefully adjusting the function of crucial immune cells, scientists may have developed a completely new type of cancer immunotherapy—harnessing the body's immune system to attack tumors. To accomplish this, they had to thread a needle in immune function, shrinking tumors without triggering unwanted autoimmune responses.
› Verified 2 days ago